Newsletters
EARLEJNMMI Awards
The EJNMMI Awards are conferred virtually on an annual basis during the EANM Annual Congress. These awards, designated for all journals within the EJNMMI Journal Family, are intended by the Editors-in-Chief to acknowledge and honour the exceptional contributions of researchers in the fields of nuclear medicine and molecular medicine.
The European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI), under the editorship of Professor Arturo Chiti, is a peer-reviewed hybrid journal. It primarily publishes clinically related content in the realms of nuclear medicine and molecular imaging. Renowned for its highly cited and extensively downloaded articles, the journal ensures global visibility for the work of its contributors.
Overview over past winners
EJNMMI Most Cited Paper Award
225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.
Mike Sathekge, Frank Bruchertseifer, Otto Knoesen, Florette Reyneke, Ismaheel Lawal, Thabo Lengana, Cindy Davis, Johncy Mahapane, Ceceila Corbett, Mariza Vorster & Alfred Morgenstern
Eur J Nucl Med Mol Imaging 46, 129–138 (2019). doi: 10.1007/s00259-018-4167-0
EJNMMI Best Paper Award
[18F]AlF-NOTA-FAPI-04: FAP-targeting specificity, biodistribution, and PET/CT imaging of various cancers
Yuchun Wei, Jinsong Zheng, Li Ma, Xiaoli Liu, Shengnan Xu, Shijie Wang, Jinli Pei, Kai Cheng, Shuanghu Yuan & Jinming Yu
Eur J Nucl Med Mol Imaging 49, 2761–2773 (2022). doi: 10.1007/s00259-022-05758-0
EJNMMI Research Best Paper Award
First-in-human use of 11C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor.
Jennifer M. Coughlin, Yong Du, Wojciech G. Lesniak, Courtney K. Harrington, Mary Katherine Brosnan, Riley O’Toole, Adeline Zandi, Shannon Eileen Sweeney, Rehab Abdallah, Yunkou Wu, Daniel P. Holt, Andrew W. Hall, Robert F. Dannals, Lilja Solnes, Andrew G. Horti & Martin G. Pomper
EJNMMI Res 12, 64 (2022). doi: 10.1186/s13550-022-00929-4
EJNMMI Physics Best Paper Award
Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model.
E. Courtney Henry, Matthew Strugari, George Mawko, Kimberly Brewer, David Liu, Andrew C. Gordon, Jeffrey N. Bryan, Charles Maitz, Robert Abraham, S. Cheenu Kappadath & Alasdair Syme
EJNMMI Phys 9, 21 (2022). doi: 10.1186/s40658-022-00447-1
EJNMMI Radiopharmacy and Chemistry Best Paper Award
Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology.
Martha Sahylí Ortega Pijeira, Herlys Viltres, Jan Kozempel, Michal Sakmár, Martin Vlk, Derya İlem-Özdemir, Meliha Ekinci, Seshasai Srinivasan, Amin Reza Rajabzadeh, Eduardo Ricci-Junior, Luciana Magalhães Rebelo Alencar, Mohammed Al Qahtani & Ralph Santos-Oliveira
EJNMMI radiopharm. chem. 7, 8 (2022). doi: 10.1186/s41181-022-00161-4
European Journal of Hybrid Imaging Best Paper Award
Diagnostic value of hybrid FDG-PET/MR imaging of chronic osteomyelitis.
Dennis Jan Willem Hulsen, Cristina Mitea, Jacobus J. Arts, Daan Loeffen & Jan Geurt
European J Hybrid Imaging 6, 15 (2022). doi: 10.1186/s41824-022-00125-6
EJNMMI Most Cited Paper Award
Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.
François Lucia, Dimitris Visvikis, Marie-Charlotte Desseroit, Omar Miranda, Jean-Pierre Malhaire, Philippe Robin, Olivier Pradier, Mathieu Hatt & Ulrike Schick
Eur J Nucl Med Mol Imaging 45,768–786 (2018). doi: 10.1007/s00259-017-3898-7
EJNMMI Best Paper Award
Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings.
Haojun Chen, Liang Zhao, Dan Ruan, Yizhen Pang, Bing Hao, Yaqing Dai, Xiurong Wu, Wei Guo, Chunlei Fan, Jingxun Wu, Weipeng Huang, Qin Lin, Long Sun & Hua Wu
Eur J Nucl Med Mol Imaging 48, 73–86 (2021). doi: 10.1007/s00259-020-04940-6
EJNMMI Best Paper Award
Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.
Paul Blanc-Durand, Simon Jégou, Salim Kanoun, Alina Berriolo-Riedinger, Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Thomas Carlier, Steven Le Gouill, René-Olivier Casasnovas, Michel Meignan & Emmanuel Itti
Eur J Nucl Med Mol Imaging 48, 1362–1370 (2021). doi: 10.1007/s00259-020-05080-7
EJNMMI Best Paper Award
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer – the SALT trial -.
H. E. Jansen, Y. J. L. Bodar, G. J. C. Zwezerijnen, D. Meijer, J. P. van der Voorn, J. A. Nieuwenhuijzen, M. Wondergem, T. A. Roeleveld, R. Boellaard, O. S. Hoekstra, R. J. A. van Moorselaar, D. E. Oprea-Lager & A. N. Vis
Eur J Nucl Med Mol Imaging 48, 509–520 (2021). doi: 10.1007/s00259-020-04974-w
EJNMMI Research Best Paper Award
Assessment of early metabolic progression in melanoma patients under immunotherapy: an 18F-FDG PET/CT study.
Christos Sachpekidis, Annette Kopp-Schneider, Jessica C. Hassel & Antonia Dimitrakopoulou-Strauss
EJNMMI Res 11,89 (2021). doi: 10.1186/s13550-021-00832-4
EJNMMI Physics Best Paper Award
Artificial intelligence for reduced dose 18F-FDG PET examinations: a real-world deployment through a standardized framework and business case assessment.
Katia Katsari, Daniele Penna, Vincenzo Arena, Giulia Polverari, Annarita Ianniello, Domenico Italiano, Rolando Milani, Alessandro Roncacci, Rowland O. Illing & Ettore Pelosi
EJNMMI Phys 8, 25 (2021). doi: 10.1186/s40658-021-00374-7
EJNMMI Radiopharmacy and Chemistry Best Paper Award
Production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair.
Brooke L. McNeil, Andrew K. H. Robertson, Winnie Fu, Hua Yang, Cornelia Hoehr, Caterina F. Ramogida & Paul Schaffer
EJNMMI radiopharm. chem. 6, 6 (2021). doi: 10.1186/s41181-021-00121-4
European Journal of Hybrid Imaging Best Paper Award
Development of artificial intelligence in epicardial and pericoronary adipose tissue imaging: a systematic review.
Lu Zhang, Jianqing Sun, Beibei Jiang, Lingyun Wang, Yaping Zhang & Xueqian Xie
European J Hybrid Imaging 5, 14 (2021). doi: 10.1186/s41824-021-00107-0
EJNMMI Most Cited Paper Award
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
Ali Afshar-Oromieh, Tim Holland-Letz, Frederik L. Giesel, Clemens Kratochwil, Walter Mier, Sabine Haufe, Nils Debus, Matthias Eder, Michael Eisenhut, Martin Schäfer, Oliver Neels, Markus Hohenfellner, Klaus Kopka, Hans-Ulrich Kauczor, Jürgen Debus & Uwe Haberkorn
Eur J Nucl Med Mol Imaging 44, 1258–1268 (2017). doi: 10.1007/s00259-017-3711-7
EJNMMI Best Paper Award
18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases
Chunxia Qin, Fang Liu, Tzu-Chen Yen & Xiaoli Lan
Eur J Nucl Med Mol Imaging 47, 1281–1286 (2020). doi: 10.1007/s00259-020-04734-w
EJNMMI Best Paper Award
Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer
Haojun Chen, Yizhen Pang, Jingxun Wu, Liang Zhao, Bing Hao, Jing Wu, Jihong Wei, Siming Wu, Long Zhao, Zuoming Luo, Xuehua Lin, Chengrong Xie, Long Sun, Qin Lin & Hua Wu
Eur J Nucl Med Mol Imaging47,1820–1832 (2020). doi: 10.1007/s00259-020-04769-z
EJNMMI Best Paper Award
[18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients
Elin Pauwels, Frederik Cleeren, Térence Tshibangu, Michel Koole, Kim Serdons, Jeroen Dekervel, Eric Van Cutsem, Chris Verslype, Koen Van Laere, Guy Bormans & Christophe M. Deroose
Eur J Nucl Med Mol Imaging 47, 3033–3046 (2020). doi: 10.1007/s00259-020-04918-4
EJNMMI Research Best Paper Award
Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images
Matteo Bauckneht, Rita Lai, Alberto Miceli, Daniela Schenone, Vanessa Cossu, Maria Isabella Donegani, Stefano Raffa, Anna Borra, Stefano Marra, Cristina Campi, Annamaria Orengo, Anna Maria Massone, Alberto Tagliafico, Claudia Caponnetto, Corrado Cabona, Angelina Cistaro, Adriano Chiò, Silvia Morbelli, Flavio Nobili, Gianmario Sambuceti, Michele Piana & Cecilia Marini
EJNMMI Res 10, 23 (2020). doi: 10.1186/s13550-020-0607-5
EJNMMI Physics Best Paper Award
Evaluation of a new multipurpose whole-body CzT-based camera: comparison with a dual-head Anger camera and first clinical images
Cédric Desmonts, Mohammed Abdeldjalil Bouthiba, Blandine Enilorac, Catherine Nganoa, Denis Agostini & Nicolas Aide
EJNMMI Phys7, 18 (2020). doi: 10.1186/s40658-020-0284-5
EJNMMI Radiopharmacy and Chemistry Best Paper Award
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Melissa E. Rodnick, Carina Sollert, Daniela Stark, Mara Clark, Andrew Katsifis, Brian G. Hockley, D. Christian Parr, Jens Frigell, Bradford D. Henderson, Monica Abghari-Gerst, Morand R. Piert, Michael J. Fulham, Stefan Eberl, Katherine Gagnon & Peter J. H. Scott
EJNMMI radiopharm. chem. 5, 25 (2020). doi: 10.1186/s41181-020-00106-9
European Journal of Hybrid Imaging Best Paper Award
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis
Sungmin Woo, Soleen Ghafoor, Anton S. Becker, Sangwon Han, Andreas G. Wibmer, Hedvig Hricak, Irene A. Burger, Heiko Schöder & Hebert Alberto Vargas
European J Hybrid Imaging 4, 16 (2020). doi: 10.1186/s41824-020-00085-9
EJNMMI Most Cited Paper Award
Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer
Thomas Pyka, Shozo Okamoto, Marielena Dahlbender, Robert Tauber, Margitta Retz, Matthias Heck, Nagara Tamaki, Markus Schwaiger, Tobias Maurer & Matthias Eiber
Eur J Nucl Med Mol Imaging43,2114–2121 (2016). doi: 10.1007/s00259-016-3435-0
EJNMMI Best Paper Award
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
Cristina Müller, Christoph A. Umbricht, Nadezda Gracheva, Viviane J. Tschan, Giovanni Pellegrini, Peter Bernhardt, Jan Rijn Zeevaart, Ulli Köster, Roger Schibli & Nicholas P. van der Meulen
Eur J Nucl Med Mol Imaging46,1919–1930 (2019). doi: 10.1007/s00259-019-04345-0
EJNMMI Best Paper Award
First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Jie Zang, Xinrong Fan, Hao Wang, Qingxing Liu, Jingnan Wang, Hui Li, Fang Li, Orit Jacobson, Gang Niu, Zhaohui Zhu & Xiaoyuan Chen
Eur J Nucl Med Mol Imaging 46, 148–158 (2019). doi: 10.1007/s00259-018-4096-y
EJNMMI Best Paper Award
Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors
Simone Krebs, Neeta Pandit-Taskar, Diane Reidy, Bradley J. Beattie, Serge K. Lyashchenko, Jason S. Lewis, Lisa Bodei, Wolfgang A. Weber & Joseph A. O’Donoghue
Eur J Nucl Med Mol Imaging 46, 677–685 (2019).
doi: 10.1007/s00259-018-4193-y
EJNMMI Research Best Paper Award
Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST
Lucas Goldfarb, Boris Duchemann, Kader Chouahnia, Laurent Zelek & Michael Soussan
EJNMMI Res 9, 8 (2019). doi: 10.1186/s13550-019-0473-1
EJNMMI Physics Best Paper Award
Accelerated SPECT image reconstruction with FBP and an image enhancement convolutional neural network
Martijn M. A. Dietze, Woutjan Branderhorst, Britt Kunnen, Max A. Viergever & Hugo W. A. M. de Jong
EJNMMI Phys 6, 14 (2019). doi: 10.1186/s40658-019-0252-0
EJNMMI Radiopharmacy and Chemistry Best Paper Award
[11C]Carbon monoxide: advances in production and application to PET radiotracer development over the past 15 years
Carlotta Taddei & Victor W. Pike
EJNMMI radiopharm. chem.4,25 (2019). doi: 10.1186/s41181-019-0073-4
European Journal of Hybrid Imaging Best Paper Award
Cardiac PET/MRI—an update
Rischpler, S. G. Nekolla, G. Heusch, L. Umutlu, T. Rassaf, P. Heusch, K. Herrmann & F. Nensa
European J Hybrid Imaging3, 2 (2019). doi: 10.1186/s41824-018-0050-2
EJNMMI Most Cited Paper Award
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh, Eleni Avtzi, Frederik L. Giesel, Tim Holland-Letz, Heinz G. Linhart, Matthias Eder, Michael Eisenhut, Silvan Boxler, Boris A. Hadaschik, Clemens Kratochwil, Wilko Weichert, Klaus Kopka, Jürgen Debus & Uwe Haberkorn
Eur J Nucl Med Mol Imaging (2015) 42: 197. doi:10.1007/s00259-014-2949-6
EJNMMI Best Paper Award
177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment
Madhav Prasad Yadav, Sanjana Ballal, Madhavi Tripathi, Nishikant Avinash Damle, Ranjit Kumar Sahoo, Amlesh Seth & Chandrasekhar Bal
Eur J Nucl Med Mol Imaging (2017) 44: 81. doi: 10.1007/s00259-016-3481-7
EJNMMI Best Paper Award
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET
Danielle J. Vugts, Chris Klaver, Claudia Sewing, Alex J. Poot, Kevin Adamzek, Seraina Huegli, Cristina Mari, Gerard W. M. Visser, Ibai E. Valverde, Gilles Gasser, Thomas L. Mindt & Guus A. M. S. van Dongen
Eur J Nucl Med Mol Imaging (2017) 44: 286. doi: 10.1007/s00259-016-3499-x
EJNMMI Best Paper Award
Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC
Kyoichi Kaira, Tetsuya Higuchi, Ichiro Naruse, Yukiko Arisaka, Azusa Tokue, Bolag Altan, Satoshi Suda, Akira Mogi, Kimihiro Shimizu, Noriaki Sunaga, Takeshi Hisada, Shigehisa Kitano, Hideru Obinata, Takehiko Yokobori, Keita Mori, Masahiko Nishiyama, Yoshihito Tsushima & Takayuki Asao
Eur J Nucl Med Mol Imaging (2018) 45: 56. doi: 10.1007/s00259-017-3806-1
EJNMMI Research Best Paper Award
PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
Erica M. Richards, Paolo Zanotti-Fregonara, Masahiro Fujita, Laura Newman, Cristan Farmer, Elizabeth D. Ballard, Rodrigo Machado-Vieira, Peixiong Yuan, Mark J. Niciu, Chul Hyoung Lyoo, Ioline D. Henter, Giacomo Salvadore, Wayne C. Drevets, Hartmuth Kolb, Robert B. Innis & Carlos A. Zarate Jr
EJNMMI Research, Volume 8, Article number: 57 (2018). doi: 10.1186/s13550-018-0401-9
EJNMMI Physics Best Paper Award
Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
Anna Sundlöv, Johan Gustafsson, Gustav Brolin, Nadja Mortensen, Rebecca Hermann, Peter Bernhardt, Johanna Svensson, Michael Ljungberg, Jan Tennvall & Katarina Sjögreen Gleisner
EJNMMI Physics, Volume 5, Article number: 12 (2018). doi: 10.1186/s40658-018-0210-2
EJNMMI Radiopharmacy and Chemistry Best Paper Award
Production of novel diagnostic radionuclides in small medical cyclotrons
Mateusz Adam Synowiecki, Lars Rutger Perk & J. Frank W. Nijsen
EJNMMI Radiopharmacy and Chemistry, Volume 3, Article number: 3 (2018). doi: 10.1186/s41181-018-0038-z
European Journal of Hybrid Imaging Best Paper Award
The role of hybrid bone SPECT/CT imaging in the work-up of the limping patient: a symptom-based and joint-oriented review
H. K. Mohan, K. Strobel, W. van der Bruggen, G. Gnanasegaran, W. U. Kampen, T. Kuwert, T. Van den Wyngaert & F. Paycha
European Journal of Hybrid Imaging, Volume 2, Article number: 8 (2018). doi: 10.1186/s41824-018-0026-2
EJNMMI Most Cited Paper Award
Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience
Afshar-Oromieh, U. Haberkorn, H. P. Schlemmer, et al.
Eur J Nucl Med Mol Imaging (2014) 41: 887. DOI 10.1007/s00259-013-2660-z
EJNMMI Most Cited Paper Award
Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT
Johannes Schwenck, Hansjoerg Rempp, Gerald Reischl, et al.
Eur J Nucl Med Mol Imaging (2017) 44: 92. DOI 10.1007/s00259-016-3490-6
EJNMMI Best Paper Award
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
Frederik L. Giesel, Hadaschik, J. Cardinale, et al.
Eur J Nucl Med Mol Imaging (2017) 44: 678. DOI 10.1007/s00259-016-3573-4
EJNMMI Best Paper Award
68Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour
Christian Uprimny, Alexander Stephan Kroiss, Clemens Decristoforo, et al.
Eur J Nucl Med Mol Imaging (2017) 44: 941. DOI 10.1007/s00259-017-3631-6
EJNMMI Physics Best Paper Award
Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey
Katarina Sjögreen Gleisner, Emiliano Spezi, Pavel Solny, et al.
EJNMMI Physics (2017) 4:28. DOI: 10.1186/s40658-017-0193-4
EJNMMI Research Best Paper Award
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
Christoph A. Umbricht, Martina Benešová, Raffaella M. Schmid, et al.
EJNMMI Research (2017) 7:9. DOI 10.1186/s13550-017-0257-4
EJNMMI Radiopharmacy and Chemistry Best Paper Award
47Sc as useful β–-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
Katharina A. Domnanich, Cristina Müller, Martina Benešová, et al.
EJNMMI Radiopharmacy and Chemistry (2017) 2:5. DOI 10.1186/s41181-017-0024-x
European Journal of Hybrid Imaging Best Paper Award
Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer
Ichiei Kuji, Tomohiko Yamane, Akira Seto, et al.
European Journal of Hybrid Imaging, EJNMMI Multimodality Journal (2017) 1:2. DOI 10.1186/s41824-017-0006-y
EJNMMI Most Cited Paper Award
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
Afshar-Oromieh, A., Malcher, A., Eder, M. et al.
Eur J Nucl Med Mol Imaging (2013) 40: 486. doi: 10.1007/s00259-012-2298-2
EJNMMI Most Cited Paper Award
68Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients”
Sterzing, F., Kratochwil, C., Fiedler, H. et al.
Eur J Nucl Med Mol Imaging (2016) 43: 34. doi:10.1007/s00259-015-3188-1
EJNMMI Best Paper Award
Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score
Verburg, F.A., Pfister, D., Heidenreich, A. et al.
Eur J Nucl Med Mol Imaging (2016) 43: 397. doi:10.1007/s00259-015-3240-1
EJNMMI Best Paper Award
Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
Freitag, M.T., Radtke, J.P., Hadaschik, B.A. et al.
Eur J Nucl Med Mol Imaging (2016) 43: 70. doi: 10.1007/s00259-015-3206-3
EJNMMI Physics Best Paper Award
Physics of pure and non-pure positron emitters for PET: a review and a discussion
Conti, M., Eriksson, L.
EJNMMI Phys (2016) 3:8. doi: 10.1186/s40658-016-0144-5
EJNMMI Research Best Paper Award
The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models
Heinzmann, K. et al.
EJNMMI Research (2016) 6:63. doi:10.1186/s13550-016-0218-3
EJNMMI Radiopharmacy and Chemistry Best Paper Award
New protein deposition tracers in the pipeline
Jovalekic, A. et al.
EJNMMI Radiopharmacy and Chemistry (2016) 1:11. doi: 10.1186/s41181-016-0015-3
EJNMMI Most Cited Paper Award
Prognostic value of metabolic tumor burden on F-18-FDG PET in nonsurgical patients with non-small cell lung cancer
Liao, S., Penney, B.C., Wroblewski, K. et al.
Eur J Nucl Med Mol Imaging (2012) 39: 27. doi:10.1007/s00259-011-1934-6
EJNMMI Best Paper Award
The diagnostic value of PET/CT imaging with the Ga-68-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate
Afshar-Oromieh, A., Avtzi, E., Giesel, F.L. et al.
Eur J Nucl Med Mol Imaging (2015) 42: 197. doi:10.1007/s00259-014-2949-6
EJNMMI Best Paper Award
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
Bodei, L., Kidd, M., Paganelli, G. et al.
Eur J Nucl Med Mol Imaging (2015) 42: 5. doi:10.1007/s00259-014-2893-5
EJNMMI Best Paper Award
F-18]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease
Harada, R., Okamura, N., Furumoto, S. et al.
Eur J Nucl Med Mol Imaging (2015) 42: 1052. doi:10.1007/s00259-015-3035-4
EJNMMI Physics Most Downloaded Paper
Increased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency
Högberg, J., Rizell, M., Hultborn, R. et al.
EJNMMI Phys (2015) 2: 10. doi:10.1186/s40658-015-0113-4
EJNMMI Research Most Cited Paper
Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET
Notni, J., Pohle, K. & Wester, H.
EJNMMI Res (2012) 2: 28. doi:10.1186/2191-219X-2-28
EJNMMI Most Cited Paper
Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data
V. Schulz, I. Torres-Espallardo, S. Renisch, Z. Hu, N. Ojha et al.
Eur J Nucl Med Mol Imaging (2011) 38:138–152 DOI 10.1007/s00259-010-1603-1
EJNMMI Best Paper
Volume-based assessment by 18F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer
J.Y. Choi, S. Hyup Hyun, H. Kyung Ahn, Hojoong Kim, Myung-Ju Ahn, Keunchil Park et al.
Eur J Nucl Med Mol Imaging (2014) 41:50–58 DOI 10.1007/s00259-013-2530-8
EJNMMI Best Paper
In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
V.L. Villemagne, S. Furumoto, M.T. Fodero-Tavoletti, R. S.Mulligan, John Hodges et al.
Eur J Nucl Med Mol Imaging (2014) 41:816–826 DOI 10.1007/s00259-013-2681-7
EJNMMI Best Paper
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
A. Afshar-Oromieh, C. M. Zechmann, A. Malcher, Matthias Eder, Michael Eisenhut et al.
Eur J Nucl Med Mol Imaging (2014) 41:11–20 DOI 10.1007/s00259-013-2525-5
EJNMMI Best Technical Paper
Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT
Dr. Carl von Gall
January 2013, Volume 40, Issue 1, pp 12-21
EJNMMI Best Basic Science Paper
Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer’s disease pathology
Dr. Nobuyuki Okamura
January 2013, Volume 40, Issue 1, pp 125-132
EJNMMI Best Clinical Paper
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
Dr. Afshar-Oromieh
April 2013, Volume 40, Issue 4, pp 486-495
EJNMMI Most Cited Paper
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Prof. Ronald Boellaard
January 2010, Volume 37, Issue 1, pp 181-200